Dr. Sameer Kumar Mehta, MD

Dr. Mehta practices at Saint Joseph Hospital in Denver, Colorado, part of Intermountain Health.

Dr. Mehta's NPI, 1023100062, was assigned on September 28, 2006. Dr. Mehta graduated from SIU School of Medicine in 1999. Dr. Mehta holds Colorado license 46795.

Dr. Mehta's primary practice is Saint Joseph Hospital, at 1375 E 19th Ave, Denver, CO 80218 in Denver County. The practice phone is (303) 812-2000.

Dr. Mehta's primary practice is Saint Joseph Hospital in Denver, Colorado, part of Intermountain Health. Dr. Mehta is also affiliated with HCA HealthONE Rose. The medical group on file is Intermountain Health. Dmand AI also links Dr. Mehta to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehta practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mehta's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mehta is board certified in interventional cardiology by the American Board of Internal Medicine. Dmand AI has Dr. Mehta's licenses on file in 2 states: Colorado and Texas.

Dmand AI lists angioplasty, cardiac catheterization and leg revascularization among the conditions Dr. Mehta treats.

CMS data shows 2,800 Medicare services from Dr. Mehta across 34 procedure codes in 2024, for 1,385 Medicare patients. Medicare paid $135,481 for them.

CMS counts 1,385 Medicare patients who saw Dr. Mehta in 2024. The largest group is 75 to 84, with 552 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehta's median patient age at 74, with 50% women.

In 2024, Dr. Mehta wrote 1,153 Medicare Part D claims for 260 patients. 69% of them were for generic drugs. CMS names the drug for 993 of them, across 18 drugs with 11 or more claims each, at $364,851 in total drug cost. In 2023, CMS named 861 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mehta for performance year 2024, reported as part of a group. Dr. Mehta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mehta as offering telehealth. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Mehta, more than 76% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Mehta. The most frequent topics are Echocardiography, Heart Failure and Black or African American. Dr. Mehta has published most often in Cardiol Rev. Dr. Mehta's most frequent co-authors are James Andrew De Lemos, MD, Mark Howard Drazner, MD and Christopher Glen Blewett, MD.

Dmand AI links Dr. Mehta to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases. Open Payments lists research payments to Dr. Mehta that name 1 trial.

CMS Open Payments shows 675 general payments to Dr. Mehta from 56 drug and device companies from 2016 to 2025. Compensation for serving as faculty or as a speaker for a medical education program make up the largest share, 34% of the total. ShockWave Medical, Inc paid the most, $52,065. It also lists 1 research payment totaling $1,575 in 2016, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. Mehta, most recently 5280 top docs in 2024.

Dr. Mehta graduated from SIU School of Medicine in 1999.

Dr. Mehta is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.